Savara SVRA Stock
$5.13
-2.471480%
Add to favorites
SECTOR
INDUSTRY
COUNTRY
Exchange
Market Cap
$1.05B
LOW - HIGH [24H]
$5.11
-
$5.35
VOLUME [24H]
$1.13M
P/E Ratio
0
Earnings per share
-$0.56
ISIN
US8051111016
Savara Price Chart
Savara SVRA Financial and Trading Overview
| Savara stock price | 5.13 USD |
| Previous Close | 5.3 USD |
| Open | 5.33 USD |
| Bid | 3.81 USD x 200 |
| Ask | 5.31 USD x 100 |
| Day's Range | 5.29 - 5.36 USD |
| 52 Week Range | 3.34 - 7.01 USD |
| Volume | 223.45K USD |
| Avg. Volume | 1.75M USD |
| Market Cap | 1.09B USD |
| Beta (5Y Monthly) | 0.252 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.56 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 10.94 USD |
SVRA Valuation Measures
| Enterprise Value | 1.2B USD |
| Trailing P/E | N/A |
| Forward P/E | -17.051283 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 7.665706 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -8.427 |
Trading Information
Savara Stock Price History
| Beta (5Y Monthly) | 0.252 |
| 52-Week Change | 46.81% |
| S&P500 52-Week Change | 15.74% |
| 52 Week High | 7.01 USD |
| 52 Week Low | 3.34 USD |
| 50-Day Moving Average | 5.6 USD |
| 200-Day Moving Average | 5.6 USD |
SVRA Share Statistics
| Avg. Volume (3 month) | 1.75M USD |
| Avg. Daily Volume (10-Days) | 1.28M USD |
| Shares Outstanding | 205.46M |
| Float | 129.8M |
| Short Ratio | 26.43 |
| % Held by Insiders | 2.58% |
| % Held by Institutions | 106.66% |
| Shares Short | 41.43M |
| Short % of Float | 23.57% |
| Short % of Shares Outstanding | 20.16% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -50.14% |
| Return on Equity (ttm) | -105.47% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -86843000 USD |
| EBITDA | -142699008 USD |
| Net Income Avi to Common (ttm) | -139308992 USD |
| Diluted EPS (ttm) | -0.58 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 174.82M USD |
| Total Cash Per Share (mrq) | 0.69 USD |
| Total Debt (mrq) | 30.41M USD |
| Total Debt/Equity (mrq) | 21.17 USD |
| Current Ratio (mrq) | 10.132 |
| Book Value Per Share (mrq) | 0.694 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -110380000 USD |
| Levered Free Cash Flow (ttm) | -57186376 USD |
Profile of Savara
| Country | United States |
| State | PA |
| City | Yardley |
| Address | The Tannery Building |
| ZIP | 19067 |
| Phone | (512) 614-1848 |
| Website | https://www.savarapharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 70 |
Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases in the United States. The company's lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. Savara Inc. was founded in 2007 and is headquartered in Yardley, Pennsylvania.
Q&A For Savara Stock
What is a current SVRA stock price?
Savara SVRA stock price today per share is 5.13 USD.
How to purchase Savara stock?
You can buy SVRA shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Savara?
The stock symbol or ticker of Savara is SVRA.
Which industry does the Savara company belong to?
The Savara industry is Biotechnology.
How many shares does Savara have in circulation?
The max supply of Savara shares is 205.46M.
What is Savara Price to Earnings Ratio (PE Ratio)?
Savara PE Ratio is now.
What was Savara earnings per share over the trailing 12 months (TTM)?
Savara EPS is -0.56 USD over the trailing 12 months.
Which sector does the Savara company belong to?
The Savara sector is Healthcare.
Savara SVRA included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
25978.42 USD — |
-0.01
|
9.18B USD — | 25802.96 USD — | 26225.09 USD — | — - | 9.18B USD — |
|
US Tech Global Select Market Com
NQGS
US
|
12767.2 USD — |
-0.02
|
— — | 12681.67 USD — | 12888.62 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1298.81 USD — |
+0.33
|
— — | 1291.52 USD — | 1308.69 USD — | — - | — — |
- {{ link.label }} {{link}}
